Skip to main content
Djordje Atanackovic, MD, Hematology, Baltimore, MD

DjordjeAtanackovicMD

Hematology Baltimore, MD

Associate Professor, Internal Medicine, University of Utah Sch of Med

Dr. Atanackovic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Atanackovic's full profile

Already have an account?

  • Office

    655 W. Baltimore Street
    Baltimore, MD 21201
    Phone+1 410-706-1946
    Fax+1 410-328-6559

Education & Training

  • Freie University Berlin Faculty of Medicine
    Freie University Berlin Faculty of MedicineClass of 1998

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2020 - 2026
  • UT State Medical License
    UT State Medical License 2013 - 2026

Publications & Presentations

PubMed

Abstracts/Posters

  • B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-Analysis
    Djordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-Analysis
    Djordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • University of Maryland Greenebaum Comprehensive Cancer Center Offers Novel Next-Generation CAR T-cell Therapy for B-cell Lymphomas in First-in-Human Clinical Trial
    University of Maryland Greenebaum Comprehensive Cancer Center Offers Novel Next-Generation CAR T-cell Therapy for B-cell Lymphomas in First-in-Human Clinical TrialNovember 25th, 2024
  • New Cancer Treatment Changing Outlook for Those with Blood Cancers
    New Cancer Treatment Changing Outlook for Those with Blood CancersJuly 11th, 2022
  • COVID Vaccine Protection May Be Weaker in Some Cancer Patients. But Experts Say They Should Still Get Vaccinated
    COVID Vaccine Protection May Be Weaker in Some Cancer Patients. But Experts Say They Should Still Get VaccinatedMay 17th, 2021
  • Join now to see all